Form 4 Filing for Alignment Healthcare, Inc.

John E. Kao, Chief Executive Officer and Director of Alignment Healthcare, Inc. (ALHC), reported the sale of 250,000 shares of Common Stock on April 7, 2026, pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2025. The sales were executed at a weighted-average price, with individual transactions ranging from $20.18 to $21.56 per share. Following these transactions, Mr. Kao directly holds 1,784,868 shares. The reported sales are attributed to JEK Trust, of which Mr. Kao is the trustee. This filing is a standard disclosure of insider transactions.